MEGA GENOMICS: INSIDE INFORMATION(1) SUPPLEMENTAL ANNOUNCEMENT IN RELATION TOTHE DELAY IN PUBLICATION OFTHE 2024 ANNUAL RESULTS ANNOUNCEMENT; AND(2) CONTINUED SUSPENSION OF TRADING

HKEXApr 21 19:04 ET · Announcements

Investors who bought high-level pharmaceutical Funds have hope! More than 80% of products achieved positive returns in the first quarter, and recovering losses is promising.

① A total of 264 medical Funds had positive returns in the first quarter of this year, accounting for over 80%, with many Funds achieving returns exceeding 15% this year. ② The net value of medical Funds established in 2020 and 2021 is currently being repaired, and investors who entered at high levels are expected to break even.

cls.cnApr 1 03:04 ET

Mei Yin Gene (06667.HK) was suspended this morning.

Gelonghui, April 1丨Meiyin Gene (06667.HK) announced that the company's shares will be suspended from trading starting today (April 1, 2025) at 9:00 AM.

Gelonghui FinanceMar 31 20:19 ET

Mega Genomics Faces Delay in Annual Results Publication

TipRanksMar 31 19:42 ET

Express News | Mega Genomics Ltd - Trading in Shares of Company Will Be Suspended From on 1 April

ReutersMar 31 19:11 ET

MEGA GENOMICS: INSIDE INFORMATION (1) DELAY IN PUBLICATION OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024; (2) POSTPONEMENT OF THE BOARD MEETING; AND (3) SUSPENSION OF TRADING

HKEXMar 31 19:10 ET · Announcements